Zim Laboratories Ltd
Know More120.50↑0.75 (0.63%)
03:56 PM,29th Sep 2023121.50↑1.15 (0.96%)
04:01 PM,29th Sep 2023BSE : 541400
NSE : ZIMLAB
Sector : Health care
ISIN Code : INE518E01015
- NSE
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: Sep 29 2023 | 04:01 PM IST
| Market Cap (₹ Cr) | 587 |
Turnover (₹ Cr) | 0.37 |
Volume (Shares) | 305020 |
Face Value | 10 |
52-WK High | 152.70 |
52-WK High Date | 04 Aug 2023 |
52-WK Low | 68.05 |
52-WK Low Date | 29 Mar 2023 |
All Time High | 152.70 |
All Time High Date | 04 Aug 2023 |
All Time Low | 68.05 |
All Time Low Date | 29 Mar 2023 |
Zim Laboratories Ltd
428407/02/96VATSALA Zim Laboratories Ltd --------------------------------------------------The Company was incorporated in the state of Maharashtra under the name and style of Zim Laboratories Pvt. Ltd. The company is engaged in manufacturing pharmaceutical products in the form of Tablets Capsules and Syrups. The Company became a Public Ltd. Company by passing special resolution and fresh certificate of incorporation was obtained from Registrar of the Companies Maharashtra Bombay. The company commenced commercial production and there was no delay in implementation of the project.The company is presently engaged in the manufacturing and trading of a variety of formulations in the field of antibiotics antibacterials analgesics etc. both as branded and generic products. The Pharma Industry is dominated by Multinationals Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector.
News
View MoreAnnouncement
View MoreZim Laboratories Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 587 |
| EPS - TTM (₹) [S] | 3.95 |
| P/E Ratio (X) [S] | 3.02 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 5.00 |
| Latest Dividend Date | 19 Sep 2019 |
| Dividend Yield (%) | - |
| Book Value Share (₹) [S] | 39.85 |
| P/B Ratio (₹) [S] | 3.02 |
| [*C] Consolidated [*S] Standalone | |
Funds Owing this Stock
| Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
|---|
Research Reports
| Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
|---|---|---|---|---|
| Data Not Found |
Stock Strength
| Today's Low/High | 118.60 122.70 |
| Week Low/High | 116.30 127.00 |
| Month Low/High | 114.45 134.00 |
| Year Low/High | 68.05 153.00 |
| All time Low/High | 14.00 153.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 0.96% | 1.01% | -0.27 | -0.18% |
| 1 Month | -3.56% | -3.91% | 1.16 | 1.53% |
| 3 Month | 9.75% | 10.35% | 2.99 | 3.51% |
| 6 Month | 65.68% | 69.24% | 14.26 | 15.85% |
| 1 Year | 53.21% | % | 16.70 | 16.77% |
| 3 Year | 291.87% | % | 73.35 | 74.99% |
Financials
- Financial Overview
- Income Statement
- Balance Sheet
- Profit & Loss
- Cash Flow Statement
- Ratios
- Revenue (Rs Cr)
- Net Profit (Rs Cr)
- Operating Profit (Rs Cr)
- Earnings Per Share(Rs)
- Book Value(Rs per share)
- Net Worth(Rs Cr)
- Divident(%)
- Dividend Payout(Rs Cr)
Bulk/ Block
| Date | Client Name | Exchange | Transaction | Quantity | Price |
|---|---|---|---|---|---|
| 04-08-2023 | GRAVITON RESEARCH CAPITAL LLP | NSE | BUY | 300211 | 143.98 |
| 04-08-2023 | GRAVITON RESEARCH CAPITAL LLP | NSE | SELL | 300211 | 143.70 |
| 28-07-2023 | GRAVITON RESEARCH CAPITAL LLP | NSE | BUY | 304887 | 132.03 |
| 28-07-2023 | GRAVITON RESEARCH CAPITAL LLP | NSE | SELL | 304887 | 132.06 |
| 12-06-2023 | BONANZA COMMODITY BROKERS PRIVATE LIMITED | BSE | SELL | 375584 | 104.84 |
| 12-06-2023 | BONANZA COMMODITY BROKERS PRIVATE LIMITED | BSE | BUY | 669584 | 102.34 |
| 12-06-2023 | BONANZA COMMODITY BROKERS PRIVATE LIMITED | NSE | BUY | 152669 | 109.39 |
| 12-06-2023 | BONANZA COMMODITY BROKERS PRIVATE LIMITED | NSE | SELL | 431667 | 108.43 |
| 12-06-2023 | F3 ADVISORS PRIVATE LIMITED | NSE | BUY | 15522 | 114.81 |
| 12-06-2023 | F3 ADVISORS PRIVATE LIMITED | NSE | SELL | 365522 | 106.94 |
Load More | |||||
Peer Group Comparison
- Ratio Performance
- Stock Performance
| Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
|---|
Shareholding Pattern
- Total shareholdings
| Category | Share(%) |
|---|---|
| Promoter | 33.26 |
| Financial Institutions Banks | 0.00 |
| Foreign Institutional Investors | 0.06 |
| Insurance Companies | 0.00 |
| Mutual Funds Uti | 0.00 |
| Other Institutional Investors | 0.00 |
| Indian Public | 49.90 |
| Others Non Institutional Investors | 16.78 |
| Custodians | 0.00 |
Corporate Action
| Announcement Date | Purpose | From | To | Remarks |
|---|---|---|---|---|
| Data Not Found |
Price History
Search for Price History
| Date | Open | High | Low | Close | Shares | Trades |
|---|---|---|---|---|---|---|
| Data Not Found |
Load more
Company Info
Company Information
Chairman & Managing Director : Anwar S Daud
Director (Finance) : Zulfiquar M Kamal
Director (Operation) : Prakash Sapkal
Director (Business Developmnt) : Niraj Dhadiwal
Non-Exec. & Independent Dir. : Kavita Loya
Non-Exec. & Independent Dir. : Padmakar Joshi
Company Sec. & Compli. Officer : Piyush Nikhadi
Independent Director : Kamlesh Shende
Independent Director : Kakasaheb Mahadik
Registered Office: Sadoday Gyan (Gr Floor), Opp NADT Nelson Square,Nagpur,Maharashtra-440013 Ph: 91-712-2588070
Email:md@zimlab.in
